Esophageal Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Pathologically confirmed esophageal cancer; 2. Clinical stage I–III (according to the AJCC staging system for esophageal cancer); 3. Scheduled to undergo surgical treatment with thoracoscopy combined with laparoscopy, robotic surgery, or transcervical mediastinoscopy combined with laparoscopy; 4. Aged 18–75 years, regardless of gender; 5. Eastern Cooperative Oncology Group (ECOG) performance status score of 0–2; 6. Adequate function of major organs to tolerate surgery and follow-up; 7. Informed consent obtained from the patient and their family, voluntary participation in this study, and signed informed consent form.
Exclusion criteria
Exclusion criteria: 1. Esophageal cancer with non-squamous, non-adenocarcinoma histology; 2. Clinical stage IV (with distant metastasis); 3. Prior history of major thoracic or abdominal surgery; 4. Severe concomitant diseases of vital organs (heart, lung, liver, kidney, etc.) that preclude tolerance to surgery; 5. Concomitant other malignant tumors; 6. Presence of psychiatric disorders that preclude compliance with follow-up; 7. Pregnant or lactating women; 8. Refusal to sign the informed consent form or inability to complete the required follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| baseline characteristics;surgical outcomes ;postoperative recovery indicators;safety parameters;Long-term outcomes; | — |
Countries
China
Contacts
Fujian Medical University Union Hospital